AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2690-8808/048
Medical oncology department. Abderrahmen Mami Hospital. Ariana, Tunisia.
*Corresponding Author: Y. Zenzri, Medical oncology department. Abderrahmen Mami Hospital. Ariana, Tunisia.
Citation: Y. Zenzri, N. Daoud, H.El Benna, Y. Berrazaga, and H. Boussen, (2020) Can Nutritional Supplementation Increase the Risk Of Crizotinib-Associated Hepatotoxicity: A Clinical Case Example. J. Clin Case Rep and Stud. 1(7). Doi: 10.31579/2690-8808/048
Copyright: © 2020 Y. Zenzri,, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Received: 16 October 2020 | Accepted: 30 November 2020 | Published: 20 November 2020
Keywords: crizotinib; bergamot; hepatotoxicity
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death. The identification of oncogenetic driver mutation in lung cancer led to a therapeutic revolution by the discovery of targetable genetic alterations including the anaplasic lymphoma kinase (ALK) fusion oncogene and ROS1 . The tyrosine kinase inhibitor “Crizotinib” improved clinical outcome and prolonged responses. Severe hepatotoxicity is a rare adverse event .We report a case of Crizotinib-induced acute hepatitis with a probable drug-bergamot interaction
Crizotinib is a targeted therapy, tyrosine kinase inhibitor that proved its efficacy in advanced non-small cell lung cancer (NSCLC). At a conventional oral dose of 250 mg, twice daily, it is well-tolerated and the most frequently occurring adverse events graded 1, 2 are visual disorders, gastrointestinal symptoms (diarrhea, nausea-vomiting, anorexia, constipation) ,peripheral edema and neutropenia [1]. The mechanism of Criztotinib hepatotoxicity is unknown. Grade 3-4 liver toxicity is an unusual side effect. We present here a case of Crizotinib-induced severe hepatotoxicity.
A 61–year-old non smoker woman, without medical comorbidities or hepatic previous disease, presents with a 4-months history of isolated dry cough. Physical examination was normal. Etiological work-up showed the presence on CT-scan of a bulky right lung lesion, with controlateral axillary and supraclavicular lymph nodes with right pleural effusion. Bronchoscpy showed tumor localized to right upper lobar bronchus and biopsies have concluded a primary lung adenocarcinoma with positive TTF1 on immunohistochemistry( IHC). We performed a screening for anaplasic lymphoma kinase( ALK) , epidermal growth factor receptor( EGFR ) and ROS 1. ROS1 rearrangement was identified. Additional work-up showed the presence on brain magnetic resonance imaging (MRI) of cerebral, bone and lymph nodes metastases. She was diagnosed with stage IV lung cancer in February 2019.The patient's full blood count, renal and liver function tests were normal .The patient was started on tablet Crizotinib 250 mg twice per day ten days after diagnosis. Crizotinib was given as monotherapy for front line management. During the follow-up, 53 days after the beginning of Crizotinib, she presented to the emergency department with complaints of fatigue, vomiting, anorexia and nausea since 2 days. The clinical examination was normal. There was neither hepatomegaly nor jaundice. A complete blood count, kidney and liver tests were performed. Liver tests showed highly increased ALT at 2413 IU/l (45 * times the upper limit of normal), AST at 1062 IU/l (20* times the upper limit of normal), prothrombine time (PT) at 62%, while ALP, GGT and bilirubin were normal. She was admitted to the hospitalist team for management of acute hepatitis. An abdominal ultrasound was normal for liver parenchyma and bile ducts without obstruction or ischemic hepatitis.
Hepatitis B markers were negative for HBs Antigen and HBc antibodies as well as PCR testing for HCV, cytomegalovirus, herpes simplex virus and Epstein–Barr virus. The patient reported having consumed Bergamot orange during Crizotinib treatment. We decided to stop the treatment and the bergamot intake .One month after livers tests normalization, we decided to restart it at a half dose of 250 mg once daily. However, 2 days after drug reintroduction, liver tests showed hepatic cytolysis and we stopped definitely Crizotinib.
Ceritinib was the second-line drug received during three months. Treatment was started at a dose of 750 mg/day. Regular liver enzyme testing was carried out during treatment. The tests were normal. A progression of the disease was noted after 3 months of Ceritinib. The patient is on third line chemotherapy by pemetrexed and carboplatin.
This report describes a durg –induced acute hepatitis by Crizotinib , a small molecule inhibitor with multiple targets, including ALK, c-MET, and ROS1. Crizotinib is approved for the treatment of a distinct subgroup of NSCLC mediated by rearrangements of ALK or ROS1 [2, 3]. The PROFILE 1 and subsequent randomized studies proved Crizotinib efficacy ,safety and its superiority compared with chemotherapy. The most common adverse events of Crizotinib include diarrhea, constipation, abdominal pain, anorexia, nausea, visual disturbances, fatigue and peripheral edema. Potentially serious adverse effects include interstitial lung disease and QT prolongation [4]. In a recent meta-analysis about 1,908 patients from 10 clinical trials, ALT and AST all-grades increase were observed in 25.2 and 26%, respectively, while grade 3 and 4 were reported in 7 and 9.9%. Sub-group analysis showed a higher incidence of liver toxicities for ceritinib compared to Crizotinib and alectinib [5].
Ripault et alreported the first case with crizotinib-induced acute hepatitis, who relapsed after reintroduction of the treatment [6]. Profile 1014, a phase 3 study has demonstrated that grade 3 or 4 elevated aminotransferases were noted in 24 patients receiving Crizotinib [4]. A majority of these adverse events were reversible on dose interruption. Four cases of fatal hepatic failure have been reported in the literature (table 1).
The mechanism of crizotinib-induced hepatotoxicity remains unknown. Yasuda et al suggested that the underlying mechanism was partly an allergic reaction to Crizotinib or its metabolites. Dose reduction associated with oral steroids following crizotinib-induced hepatotoxicity did not improve the hepatitis. Oral desensitization may be considered as a good option following hepatitis [11]. Moreover, Ceritinib which is a small molecule tyrosine kinase receptor inhibitor could be an alternative treatment when crizotinib causes hepatotoxicity [12]. Specific risk factors for Crizotinib-induced hepatitis remain unclear. General risk factors of drug-induced hepatotoxicity are reported to be female sex , pregnancy, older age, excessive alcohol intake, smoking, HBV or HCV infection, HIV infection and genetic variability[13,14].
The use of CYP3A inducers and inhibitors like grapefruit juice must be interrupted since it may increase the plasma concentration of Crizotinib [15]. In our case, the patient reported having consumed Bergamot orange during treatment. Bergamottin is a natural furanocoumarin found in the pulp of pomelos and grapefruits. It is also found in the peel and pulp of the bergamot orange. Bergamottin was tested for its inhibitory effects on hydroxylase and O-dealkylase activities of human cytochrome P450 isoenzymes CYP 3A4 and CYP 1B1 [16].This could explain the enhancement of liver toxicity observed in our patient.
Crizotinib-induced hepatotoxicity usually occurs within the first two months of treatment. Monitoring liver function tests every two weeks is mandatory during this period. A thorough knowledge of the metabolism and pharmacologic properties of the treatment is important to prevent side effects.
Although Crizotinib is usually well tolerated, it can cause acute hepatitis in lung cancer patient. Regular liver enzyme testing should be carried out during the first two months of Crizotinib treatment. Further work should explore underlying mechanisms of these severe cases to identify risk factors that can induce hepatotoxicity.
Concepts: Nouha Daoud, Yosr Zenzri
Design: Hamouda Boussen, Nouha Daoud, Yosr Zenzri
Definition of intellectual content: Hamouda Boussen, Nouha Daoud, Yosr Zenzri, Houda El Benna
Literature search: Yosr Zenzri, Nouha Daoud
Manuscript preparation: Nouha Daoud, Yosr Zenzri, Houda El Benna
Manuscript editing: Yosr Zenzri, Nouha Daoud
Manuscript review: Yosr Zenzri, Nouha Daoud, Houda El Benna, Yosra Berrazaga
Guarantor: Hamouda Boussen, Yosr Zenzri, Nouha Daoud
Funding: Not applicable
Conflicts ofinterest: The authors declare that they have no conflicts of interest.
Acknowledgments : None
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
